Biokloot schreef op 2 juni 2022 08:10:
Exercise of a Call Option from Goldman Sachs and
Additional Information on the Financing Strategy
Liege, Belgium, 2 June 2022 – 7:30 CET – Mithra Pharmaceuticals SA (Euronext Brussels: MITRA)
(the "Company" or "Mithra"), a company dedicated to Women’s Health, today announces that Goldman
Sachs International ("GSI") has elected to exercise the last call option in relation to the outstanding
drawdown of EUR 5 million, and provides additional information on its financing strategy.
Exercise of a call option from Goldman Sachs
On 25 May 2022, GSI has elected to exercise a call option for an amount of EUR 5 million according to
the terms of the equity funding agreement signed on 4 February 20221
. This exercise resulted in the
issuance of 725,300 shares of the Company. In accordance with article 15 of the Belgian Act of 2 May
2007 on the disclosure of major participations in issuers of which shares are admitted to trading on a
regulated market and regarding miscellaneous provisions, following this capital increase’s completion,
Mithra now has 46,085,634 outstanding shares carrying voting rights (against 45,360,334 outstanding
shares carrying voting rights previously). Therefore, Mithra publishes the following updated
information:
• Capital: EUR 33,739,072.34
• Total number of securities carrying voting rights: 46,085,634 (all ordinary shares)
• Total number of voting rights (= denominator): 46,085,634 (all relating to ordinary shares)
• Number of outstanding rights to subscribe to securities carrying voting rights:
o Pursuant to the share option plan of 5 November 2018: 1,394,900 subscription rights
giving right to 1,394,900 ordinary shares
o Pursuant to the share option plan of 22 July 2020 : 690,000 subscription rights giving
right to 690,000 ordinary shares
o Pursuant to the share option plan granted to the lending shareholders of 7 September
2020: 300,000 subscription rights giving right to 300,000 ordinary shares
o Pursuant to the share option plan of 20 November 2020: 74,717 subscription rights
giving rise to 74,717 ordinary shares
Additional information on the financing strategy
Following the latest exercise of a call option by GSI, there is currently no drawing outstanding under
this equity line facility. Hence, the Company has regained access to the LDA Capital commitment,
which is still available for an amount of EUR 53 million.